The SOT-Sponsored and SOT-Hosted Meetings described below may be of interest to you. For additional information, please contact the organizers of these meetings directly.
Conferences
GRC Environmental Endocrine Disruptor, June 19–24
The 2016 Environmental Endocrine Disruptor Gordon Research Conference (EED-GRC) will celebrate its 10th anniversary this summer by focusing on the next generation of questions, chemicals, tools, approaches, challenges, and investigative strategies related to endocrine disruption. The EED-GRC will be held June 19–24, 2016, Sunday River, Newry, Maine. Featured themes include understanding inter-individual sensitivity, mechanisms of transgenerational inheritance, advances in high throughput screening, and emerging chemicals of concern. A primary goal of this meeting is to feature new investigators, new technology, and new areas of concern, including potential effects on pollinators. An associated Gordon Research Seminar will be held in conjunction, led and organized by trainees, and featuring work in the area of genes, genetics, and genomics. Focusing on emerging ideas and transformative approaches will be a unifying basis from which participants working on every level from molecule to man can converge and discuss the past, present, and future of the Endocrine Disruptor Chemical (EDC) field. Applications must be submitted by May 22, 2016. For additional information, please visit the conference website.
Teratology Society 56th Annual Meeting, June 25–29
The 56th Annual Meeting of the Teratology Society will be held June 25‒29, 2016, at the Grand Hyatt, San Antonio, Texas. The theme of the 2016 meeting is New Horizons in Birth Defects Research and will highlight that preventing and treating birth defects and developmental disabilities is dependent on: a) developing and integrating the latest information and technology into research; and b) recruiting, training, and mentoring the next generation of birth defects researchers. Symposia topics include early prenatal diagnosis of birth defects, testicular dysgenesis syndrome, and thrombosis during pregnancy. There will be numerous career development events designed specifically for students and new and early stage investigators. For additional information and to register, please visit the Teratology Annual Meeting website.
Society of Toxicologic Pathology 35th Annual Symposium, June 26–30
The 2016 Society of Toxicologic Pathology (STP) Annual Symposium will be held June 26–30, 2016, in San Diego, California, The symposium will focus on the basis and relevance of variation in toxicologic responses. Talks will describe key factors that impact the interpretation of nonclinical discovery and development studies. The symposium will kick off with “Real World Toxicology Outcomes: Impact of Species and Strain Selection on Drug Development Programs.” Sessions will delve deep into topics that influence the accuracy of toxicology translatability to human health, including species and strain differences, animal model selection and disease predictability, genetics and epigenetics, hormones, age, drug metabolism, the microbiome, gene-environment interactions, formulations, study design (including special points to consider when designing developmental and reproductive toxicology studies), and much more. An interactive pre-meeting National Toxicology Program Satellite Symposium will be held on Saturday, June 25, and four Continuing Education Courses will be offered on Sunday, June 26. Visit the 2016 STP Annual Meeting website for registration and additional meeting information.
Ocular Toxicology, Pharmacology and Drug Delivery: An Eye on the Future, June 27–28
This Society of Toxicology Contemporary Concepts in Toxicology (SOT CCT) conference, Ocular Toxicology, Pharmacology, and Drug Delivery: An Eye on the Future, will provide a forum for communication and interactions between toxicologists, pathologists, clinicians, pharmacologists, basic scientists, and other professionals working in the field of ocular toxicology. This SOT CCT will be held June 27–28, 2016, in South San Francisco, California. The main focus will be two-fold: to improve our understanding of ocular toxicology, pharmacology, and safety assessment and to increase our understanding of the challenges associated with the development of the next generation of ocular drugs and devices. In particular, the organizing committee has focused on the two challenges that were considered to be of the highest importance in the field. The first is immunogenicity of intravitreal therapeutics, which has become a significant issue across the industry as more intravitreal protein (or protein/polymer combination) therapeutics advance to clinical trials. Immunogenicity of these therapeutics is a significant confounding factor and often makes nonclinical risk assessment difficult. The second key issue is the development of locally-administered complex long-acting delivery technologies, including polymer, device, gene, and/or cell-based therapies. The development of these technologies is complicated by their complex and novel composition, the local cellular response often observed against these systems within the eye, and a lack of clear regulatory guidance in the field. For more information and to register, please visit the conference website.
Aryl Hydrocarbon Receptor Conference, August 3-6
The 2016 Aryl Hydrocarbon Receptor (AHR) Conference, The Aryl Hydrocarbon Receptor: A Central Mediator of Health and Disease, will be held August 3–6, 2016, in Rochester, New York. This international meeting will bring scientists from around the world to the University of Rochester to discuss emerging knowledge about the AHR and its many ligands. The purposes of this conference are to synthesize current knowledge; identify new research opportunities, gaps and challenges; build collaborations; and integrate basic and applied research across the growing subdisciplines with interest in the AHR. Topics span organ systems and disease models and will include up-to-date thinking about how the AHR is relevant to the development and function of many organ systems, to numerous diseases, as well as to drug discovery and environmental health. Abstracts submitted by June 1 will be considered for oral presentations. To ensure an interactive meeting, registration is limited, so act soon to guarantee your place. Registration closes July 15 or when the conference is full. For further information about the program, venue, confirmed speakers, on-line registration, and abstract submission, please visit the conference website.
ACT Advanced Comprehensive Toxicology Course, August 8–12
The American College of Toxicology (ACT) is offering an advanced course, Advanced Comprehensive Toxicology, to complement the Toxicology for Pharmaceutical and Regulatory Scientists course. This advanced five-day course will take place August 8–12, 2016, and attendees will be provided with detailed descriptions of the principles of toxicology, effects of xenobiotics on organ systems, discussions of specific classes of toxicants, mechanisms of toxicity, risk assessment, and other contemporary toxicological concepts. The content of this course will provide information that could be helpful to those seeking certification in toxicology or to those seeking more advanced training in toxicology. The faculty consists of well-recognized experts in their field of study and most are Board Certified by the American Board of Toxicology (ABT). This week-long course will begin on Sunday evening with an orientation and reception and will end on Friday with a practice exam, comprised of questions of the type and rigor found on the ABT exam. For more information and to register, please visit the conference website.
AMCT Board Review Course, September 29-October 1
The American College of Medical Toxicology (ACMT) Board Review Course will be held September 29–October 1, 2016, in Salt Lake City, Utah. Led by numerous nationally and internationally recognized experts in the field of medical toxicology, this course provides a broad overview of the scope of medical toxicology and a detailed perspective into current clinical and public health toxicological issues. It's an appropriate course for physicians preparing for their board exams as well as any medical professional interested in increasing his or her understanding of the impact of toxicology on human health and local communities. This course is offered only once every two years. Early bird discount pricing is available until June 30. To see a full agenda and to register, please visit the conference website.
XIV International Congress of Toxicology (ICTXIV), October 2–6
The XIV International Congress of Toxicology (ICTXIV) will be organized by the Mexican Society of Toxicology and held in Merida, Mexico, October 2–6, 2016. The International Union of Toxicology (IUTOX) organizes the largest and most prestigious International Congress on Toxicology (ICT) every three years, offering the opportunity to learn the latest developments in toxicological science and regulation through general scientific sessions and continuing education courses. The theme of the ICTXIV is Toxicology and Global Sustainability. IUTOX is proud to present this meeting where toxicologists from around the world will share their recent findings with colleagues and other ICTXIV delegates. Keynote speakers include Dr. Linda S. Birnbaum, Director, National Institute of Environmental Health Sciences; Dr. Philip J. Landrigan, Dean of Global Health, Mount Sinai Hospital; Dr. Maria Neira, Director, Public Health and Environment Department, World Health Organization; Dr. Ellen K. Silbergeld, Professor of Environmental Health Sciences, Johns Hopkins Bloomberg School of Public Health. For more information, to register, to submit an abstract, and more, please visit the conference website and/or contact mailto:ict2016@cinvestav.mx. Merida is the capital city of the State of Yucatan, Mexico, the home of the Mexican Mayan Culture.
Webinar
Advancing the Science Webinar Series: Chemical-Induced Asthma, April to October 2016
This webinar series will discuss the advances being made with chemical-induced asthma and the role of clinical, toxicological, and epidemiological research in regulatory and hazard characterization approaches. Past and future topics include: “The role of toxicology in asthma hazard assessment” (April 2016), “Environmental contributions to asthma prevalence: assessing the link between exposure and disease” (June 2016), “Asthma risk assessment: A regulatory perspective” (August 2016), and “Asthma-specific hazard characterization approaches: A novel approach to a complex problem” (October 2016). The webinar series is sponsored by the American Cleaning Institute (ACI), in collaboration with the Toxicology Excellence for Risk Assessment (TERA) Center, University of Cincinnati and endorsed by the Society of Toxicology and Society for Risk Analysis. The webinars are FREE but registration is REQUIRED. For more information on the upcoming webinar or past webinars, go to TERA or ACI website.